LOFLX
Price
$14.07
Change
+$0.12 (+0.86%)
Updated
Jun 26 closing price
Net Assets
38.15M
RMEBX
Price
$58.60
Change
+$0.43 (+0.74%)
Updated
Jun 26 closing price
Net Assets
106.24B
Interact to see
Advertisement

LOFLX vs RMEBX

Header iconLOFLX vs RMEBX Comparison
Open Charts LOFLX vs RMEBXBanner chart's image
Lord Abbett Focused Large Cap Value F3
Price$14.07
Change+$0.12 (+0.86%)
VolumeN/A
Net Assets38.15M
American Funds American Mutual R2E
Price$58.60
Change+$0.43 (+0.74%)
VolumeN/A
Net Assets106.24B
LOFLX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LOFLX vs. RMEBX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LOFLX is a Hold and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 106B vs. LOFLX (38.1M). RMEBX pays higher dividends than LOFLX: RMEBX (1.16) vs LOFLX (0.87). LOFLX was incepted earlier than RMEBX: LOFLX (6 years) vs RMEBX (11 years). LOFLX (1.37) is less costly to investors than RMEBX (1.07). LOFLX is a more actively managed with annual turnover of: 58.00 vs. RMEBX (31.00). LOFLX has a lower initial minimum investment than RMEBX: LOFLX (0) vs RMEBX (250). LOFLX annual gain was more profitable for investors over the last year : 13.47 vs. RMEBX (9.50). RMEBX return over 5 years is better than : 62.71 vs. LOFLX (14.71).
LOFLXRMEBXLOFLX / RMEBX
Total Expense Ratio0.691.0764%
Annual Report Gross Expense Ratio1.371.07128%
Fund Existence6 years11 years-
Gain YTD5.8427.31580%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets38.1M106B0%
Annual Yield % from dividends0.871.1675%
Returns for 1 year13.479.50142%
Returns for 3 years4.3725.8817%
Returns for 5 years14.7162.7123%
Returns for 10 yearsN/A74.51-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR5.310.12
+2.31%
Vir Biotechnology
SPRO2.90N/A
N/A
Spero Therapeutics
AMED98.03-0.05
-0.05%
Amedisys
SHG44.16-0.24
-0.54%
Shinhan Financial Group Co Ltd
DFDV17.94-0.92
-4.88%
DeFi Development Corp